Halozyme Therapeutics, Inc. (LON:0J2O)
London
· Delayed Price · Currency is GBP · Price in USD 60.47
-0.94 (-1.53%)
At close: Apr 30, 2025
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of 5.58 billion as of May 2, 2025. Its market cap has increased by 42.30% in one year.
Market Cap
5.58B
Enterprise Value
6.29B
Revenue
811.01M
Ranking
n/a
PE Ratio
15.73
Stock Price
60.47
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 95.57M to 5.58B, an increase of 5,738.93%. That is a compound annual growth rate of 21.39%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 163.22B |
| GSK plc | 57.05B |
| Haleon | 33.97B |
| Smith & Nephew | 8.73B |
| ConvaTec Group | 5.28B |
| Hikma Pharmaceuticals | 4.27B |
| HUTCHMED (China) | 1.92B |
| Oxford Nanopore Technologies | 1.12B |